Close
Close
Treatment Database
2,4-dinitrophenol
Trade Name not avaiable
Orphan Indication Huntington disease
USA Market Approval
USA Designation Date 11-02-2019
Sponsor Mitochon Pharmaceuticals, Inc.
970 Cross Lane
Blue Bell, Pennsylvania, 19422
More about Huntington disease
Free Newsletter
Related Videos